English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

It is now well-recognized that most intra-abdominal infections involve multiple types of bacteria. The most frequently encountered organisms in intra-abdominal infections are Escherichia coli and Bacteroides fragilis. These two micro-organisms are indigenous components of faecal microbiota, but can cause intra-abdominal abscess following surgery (Goldstein & Snydman, 2004). Therefore, an effective antimicrobial agent for the treatment of intra-abdominal infections requires a broad spectrum of activity against both aerobic and anaerobic bacteria.

Comparative activity of ertapenem and piperacillin–tazobactam in a murine systemic infection model with Bacteroides fragilis and Escherichia coli